• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchSkye Bioscience
    Picture of Skye Bioscience logo

    SKYE — Skye Bioscience News Story

    $1.540.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    • Market Cap
      $6.82m
    • Enterprise Value
      -$3.54m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • SKYE Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    SKYE Dividends
    All News

    NASDAQ RESUMED AT 09:36 AM

    Picture of Skye Bioscience logoSkye Bioscience
    14/08/2026 14:36
    NASDAQ RESUMED  AT 09:36 AM

    Recent news on Skye Bioscience

    See all news
    • RCS - Redx Pharma Limited - Redx to Present Poster on RXC008 at UEG Week

      16/10/2026 07:00
    • RCS - Redx Pharma Limited - Redx Announces ROCKETEER Phase 2 Trial for RXC008

      28/09/2026 07:00
    • Brief: Skye Bioscience Says John Sharp Resigns As CFO - SEC Filing

      11/09/2026 21:33
    • Brief: Skye Bioscience - Enters $22 Million Securities Purchase Agreement With Redmile Biopharma Investments Iii - SEC Filing

      24/08/2026 21:12
    • NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM

      24/08/2026 08:58

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.